Further Results from Bone Therapeutics ALLOB Phase I/IIA Delayed-Union Fracture Trial
Bone Therapeutics announced positive efficacy results for the 2nd patient cohort in its Phase I/IIA trial of ALLOB® allogeneic bone cell therapy product for the treatment of delayed-union fractures. May 17, 2016